REGENXBIO Inc.RGNXNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank49
3Y CAGR-30.4%
5Y CAGR-47.5%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-30.4%/yr
Quarterly compound
5Y CAGR
-47.5%/yr
Recent acceleration
Percentile
P49
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 6.47% |
| Q3 2025 | -13.51% |
| Q2 2025 | -252.53% |
| Q1 2025 | 199.70% |
| Q4 2024 | 19.99% |
| Q3 2024 | 11.09% |
| Q2 2024 | 17.93% |
| Q1 2024 | -33.72% |
| Q4 2023 | 17.62% |
| Q3 2023 | -1.90% |
| Q2 2023 | 41.80% |
| Q1 2023 | -91.20% |
| Q4 2022 | 19.21% |
| Q3 2022 | 21.81% |
| Q2 2022 | -6.14% |
| Q1 2022 | -121.46% |
| Q4 2021 | 609.18% |
| Q3 2021 | -23.11% |
| Q2 2021 | 33.77% |
| Q1 2021 | -382.43% |
| Q4 2020 | 162.49% |
| Q3 2020 | -71.68% |
| Q2 2020 | 38.38% |
| Q1 2020 | -51.50% |
| Q4 2019 | 16.63% |
| Q3 2019 | -8.63% |
| Q2 2019 | 7.71% |
| Q1 2019 | -251.67% |
| Q4 2018 | 60.62% |
| Q3 2018 | -133.95% |
| Q2 2018 | 21.06% |
| Q1 2018 | 450.29% |
| Q4 2017 | 9.43% |
| Q3 2017 | -56.61% |
| Q2 2017 | 44.98% |
| Q1 2017 | 17.89% |
| Q4 2016 | -77.04% |
| Q3 2016 | -47.72% |
| Q2 2016 | -14.48% |
| Q1 2016 | -81.65% |